XML 71 R60.htm IDEA: XBRL DOCUMENT v3.21.2
FINANCING ACTIVITIES AND OFF-BALANCE SHEET RISK - NARRATIVE (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2021
USD ($)
Feb. 28, 2021
USD ($)
tranche
$ / shares
Oct. 31, 2019
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2021
USD ($)
shares
Sep. 30, 2021
USD ($)
shares
Aug. 02, 2021
$ / shares
shares
Dec. 31, 2020
USD ($)
Oct. 31, 2020
USD ($)
Jun. 30, 2020
USD ($)
Debt Instrument [Line Items]                    
Settlement date basis, equities           2 days        
Settlement date basis, options           1 day        
Tranche 1 Convertible Note Holders                    
Debt Instrument [Line Items]                    
Aggregate proceeds invested, percentage   15.00%                
Maximum amount of all warrants   $ 379,800,000                
Percentage of per unit of warrants required to meet qualify in IPO   70.00%                
Outstanding warrants strike price (in dollars per share) | $ / shares   $ 38.29                
Common Class A | IPO                    
Debt Instrument [Line Items]                    
Aggregate warrants exercisable (in shares) | shares             14,300,000      
Conversion price (in dollars per share) | $ / shares             $ 26.60      
Exercise price (in dollars per share) | $ / shares             $ 26.60      
Common stock                    
Debt Instrument [Line Items]                    
Conversion of preferred stock to common stock (in shares) | shares         412,742,897 [1] 412,742,897 [2]        
Convertible notes                    
Debt Instrument [Line Items]                    
Number of tranches issued | tranche   2                
Interest rate on loan   6.00%                
Convertible notes | Common Class A                    
Debt Instrument [Line Items]                    
Gross proceeds from IPO offering to trigger conversion   $ 500,000,000                
Conversion price percentage, convertible debt   70.00%                
Tranche I Convertible Notes | Convertible notes                    
Debt Instrument [Line Items]                    
Notes issued   $ 2,530,000,000                
Tranche I Convertible Notes | Convertible notes | Common Class A                    
Debt Instrument [Line Items]                    
Conversion price (in dollars per share) | $ / shares   $ 38.29                
Tranche II Convertible Notes | Convertible notes                    
Debt Instrument [Line Items]                    
Notes issued   $ 1,020,000,000.00                
Tranche II Convertible Notes | Convertible notes | Common Class A                    
Debt Instrument [Line Items]                    
Conversion price (in dollars per share) | $ / shares   $ 42.12                
Revolving Credit Facility | October 2019 Credit Facility | Line of Credit                    
Debt Instrument [Line Items]                    
Line of credit facility, amount entered into     $ 200,000,000              
Commitment fee percentage     0.10%              
Outstanding borrowings, long-term         $ 0 $ 0   $ 0    
Revolving Credit Facility | October 2019 Credit Facility | Eurodollar | Line of Credit                    
Debt Instrument [Line Items]                    
Variable rate on loan     1.00%              
Revolving Credit Facility | October 2019 Credit Facility | Federal Reserve Bank of New York Rate | Line of Credit                    
Debt Instrument [Line Items]                    
Variable rate on loan     0.50%              
Revolving Credit Facility | October 2019 Credit Facility | Eurodollar, One Month Interest Period | Line of Credit                    
Debt Instrument [Line Items]                    
Variable rate on loan     1.00%              
Revolving Credit Facility | October 2019 Credit Facility, As Amended | Line of Credit                    
Debt Instrument [Line Items]                    
Line of credit facility, amount entered into $ 625,000,000               $ 600,000,000  
Revolving Credit Facility | Line of Credit | September 2019 Credit Facility                    
Debt Instrument [Line Items]                    
Line of credit facility, amount entered into       $ 400,000,000            
Outstanding borrowings, short-term               $ 0    
Commitment fee percentage       0.35%            
Revolving Credit Facility | Line of Credit | September 2019 Credit Facility | Federal Funds Rate                    
Debt Instrument [Line Items]                    
Variable rate on loan       1.25%            
Revolving Credit Facility | Line of Credit | September 2019 Credit Facility, As Amended                    
Debt Instrument [Line Items]                    
Line of credit facility, amount entered into                   $ 550,000,000
Revolving Credit Facility | Line of Credit | April 2021 Credit Facility                    
Debt Instrument [Line Items]                    
Line of credit facility, amount entered into $ 2,180,000,000                  
Outstanding borrowings, short-term         $ 0 $ 0        
Commitment fee percentage 0.50%                  
Revolving Credit Facility | Line of Credit | April 2021 Credit Facility, Tranche A | Short-Term Funding Rate                    
Debt Instrument [Line Items]                    
Variable rate on loan 1.25%                  
Revolving Credit Facility | Line of Credit | April 2021 Credit Facility, Tranche B and C | Short-Term Funding Rate                    
Debt Instrument [Line Items]                    
Variable rate on loan 2.50%                  
[1] The share amounts listed above combine common stock, Class A common stock and Class B common stock. In connection with the completion of our initial public offering, all previously outstanding shares of common stock were reclassified into Class A common stock and Class B common stock. Refer to Note 1 for more information.
[2] The share amounts listed above combine common stock, Class A common stock and Class B common stock. In connection with the completion of our initial public offering, all previously outstanding shares of common stock were reclassified into Class A common stock and Class B common stock. Refer to Note 1 for more information.